BETHANY HART: Open Payments
NPI 1528616588 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 14 payments from 4 companies in 2025. Trend: 2023 $659 · 2024 $691 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $360 |
| ViiV Healthcare Company | 4 | $96 |
| ABBVIE INC. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: Yeztugo, CABENUVA, APRETUDE, MAVYRET, PIFELTRO.
Industry payments across TX — which companies pay providers there.
